Learn About Low T

It is believed that 13 million men in the U.S. have low testosterone levels — also known as “Low T.”

Simply stated, Low T is the body’s inability to make enough testosterone, the most important sex hormone produced by males.

Indications that you may have low testosterone levels include:

  • Loss of energy and moodiness
  • Diminished sex drive and sexual function
  • Weight gain and/or loss of muscle mass
  • Loss of bone strength

Most sufferers of Low T believe their symptoms are simply a function of growing older. As a consequence, they never seek the medical attention needed. Today, low testosterone treatment options exist that can relieve the symptoms of Low T and help men reclaim their lives.

Testopel® is the ONLY FDA-approved, long-acting testosterone replacement therapy.

Your healthcare professional can insert Testopel® under the skin just above your back hip pocket during an in-office procedure that takes 10 minutes every three to six months.

In fact, this procedure is so easy that 9 of 10 men using testosterone prefer implantable testosterone pellets over other forms of therapy1. Men appreciate the benefits derived from treatment with Testopel® without the daily, time-consuming hassle of having to apply testosterone gel or the inconvenience of painful bi-weekly injections.

Do you think that you might have Low T?

Be sure to download a questionnaire, fill it out and take it with you to your next doctor visit. Ask your healthcare professional if Testopel® is the right choice to help you reclaim your life.

All forms of testosterone replacement therapy can produce side effects. Testopel® may produce the following adverse effects: breast discomfort, and/or prostate enlargement accompanied by difficulty in urinating. Patients should contact their doctors if any of these events are noticed.

Prescribing Information
Patient Safety Information

1 Handelsman DJ, Mackey MA, Howe C, Turner L, Conway AJ. An analysis of testosterone implants for androgen replacement therapy. Clin Endo. 1997;47:311-316.